GlaxoSmithKline Consumer Healthcare Q4 '07 PAT up by 22.8%, Gurgaon, Dec 31, 2007
31 December 2007
GlaxoSmithKline Consumer Healthcare records unprecedented growth for the year ended December 31, 2007
Sales up 15.3% and Profits up 28.1%
Highlights for the Year______________________________________________________
High Double digit growth in Sales and Profits in 2007 ,
Focus on existing and new product innovation with high quality products key to growth
Heavily investing behind all its brands
Continued effort in cost curtailment negates impact of rising costs
Aggressive Retention and Development programs for key talent
Efficiencies and improved processes contributes to the growth
GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the year ended December 31, 2007. Net Sales at Rs 12,778 millions recorded an impressive growth of 15.3% over 2006 with PAT at Rs. m1,626 millions growing by 28% for the same period and PBT growing by 28.6% over last year to Rs. 2,451 millions. For the Fourth Quarter, net sales were Rs. 2,841 millions, while PBT and PAT were Rs. 412 millions and Rs. 275 millions respectively.
"Strong performance in 2007 has been driven by product innovation, investment behind brands, cost containment and retention and development of our key talent" said Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Ltd.
"GSKCH's single-minded focus in 2008 year will continue to be on top line growth through customer driven innovation in existing and new product categories while continuing to invest behind our brands besides continuing our efforts on costs curtailment. The year has started with two new product launches - Women's Horlicks and a Specialist Nutrition product under Glaxo Nutrition - both products designed with specific consumer needs", he added.
About GlaxoSmithKline Consumer Healthcare Ltd.
GSKCH is an associate of GlaxoSmithKline plc. of the U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 2700 people.
GSKCH has a strong marketing and distribution network in India comprising over 1800 wholesalers and direct coverage of over 4,50,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent household names such as Eno, Crocin and Iodex.
For more information, please contact:
Head of Communications, GlaxoSmithKline Consumer Healthcare